Analysts Set Masimo Corporation (NASDAQ:MASI) Price Target at $181.17

Shares of Masimo Corporation (NASDAQ:MASI) have received an average rating of “Hold” from the nine research firms that are currently covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a sell rating, seven have issued a hold rating and one has given a buy rating to the company. The average 1 year price objective among brokerages that have updated their coverage on the stock in the last year is $181.1667.

MASI has been the subject of several analyst reports. BTIG Research lowered shares of Masimo from a “buy” rating to a “neutral” rating in a report on Wednesday, February 18th. Weiss Ratings reiterated a “sell (d)” rating on shares of Masimo in a research report on Thursday, January 22nd. Wolfe Research cut shares of Masimo from a “strong-buy” rating to a “hold” rating in a research note on Thursday, February 19th. Needham & Company LLC restated a “hold” rating on shares of Masimo in a research report on Monday, December 1st. Finally, Bank of America assumed coverage on shares of Masimo in a research note on Monday, November 17th. They set a “neutral” rating and a $162.00 target price on the stock.

Hedge Funds Weigh In On Masimo

A number of hedge funds have recently made changes to their positions in MASI. Global Retirement Partners LLC bought a new stake in Masimo during the 4th quarter valued at approximately $27,000. Aster Capital Management DIFC Ltd bought a new position in Masimo in the 4th quarter worth approximately $28,000. Los Angeles Capital Management LLC purchased a new stake in Masimo during the 4th quarter valued at approximately $31,000. MAI Capital Management grew its holdings in Masimo by 176.7% during the 2nd quarter. MAI Capital Management now owns 202 shares of the medical equipment provider’s stock valued at $34,000 after buying an additional 129 shares in the last quarter. Finally, Rothschild Investment LLC raised its position in shares of Masimo by 12,950.0% during the fourth quarter. Rothschild Investment LLC now owns 261 shares of the medical equipment provider’s stock valued at $34,000 after buying an additional 259 shares during the last quarter. Institutional investors own 85.96% of the company’s stock.

Masimo Stock Performance

NASDAQ:MASI opened at $175.42 on Monday. The company has a debt-to-equity ratio of 0.72, a quick ratio of 1.47 and a current ratio of 2.49. The stock has a 50-day simple moving average of $147.24 and a two-hundred day simple moving average of $144.82. The firm has a market capitalization of $9.42 billion, a PE ratio of -16.64, a P/E/G ratio of 1.78 and a beta of 1.21. Masimo has a 52-week low of $125.94 and a 52-week high of $175.90.

About Masimo

Masimo (NASDAQ: MASI) is a global medical technology company specializing in noninvasive monitoring solutions. The company’s flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo’s portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.

In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.